mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |